Vetter
- 1
- 2
Vetter Achieves Platinum Status as a Best Managed Company
Ravensburg, May 26, 2026: Vetter, a leading Contract Development and Manufacturing Organization (CDMO), has been named a Best Managed Company for the seventh year in a row. The family-owned business was the only company in this year’s competition to be newly awarded Platinum status. The prestigious prize is awarded by Deloitte Private, UBS, Frankfurter Allgemeine...
Vetter Starts Construction of a New Production Site in Germany
Saarlouis / Ravensburg, May 13, 2026: Vetter, a leading Contract Development and Manufacturing Organization (CDMO), is celebrating the start of construction on its new site in Saarlouis with a traditional groundbreaking ceremony today. During the first construction phase, the company will build a state-of-the-art facility for the commercial production of injectable drugs on the 95-acre...
Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements
Ravensburg, April 14, 2026: Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), announced significant progress in the continued expansion of its global clinical manufacturing network. With the ongoing scale-up of its Vetter Development Service offering, the company is taking important steps to provide necessary capacity, advanced technologies, and specialized expertise in response to...
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Ravensburg, January 29, 2026 – Vetter, one of the world's leading pharmaceutical service providers for the production of injectable drugs, has confirmed its plans to build a state-of-the-art production facility in the Saarland region of southwest Germany. This strategic investment marks a significant milestone in the company’s long-term global growth strategy. Construction is scheduled to...
Vetter Achieves Top Sustainability Rating and Expands Climate Goal Commitments
Ravensburg, January 21, 2026: Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has strengthened its sustainability strategy with distinguished recognitions: the internationally renowned EcoVadis Platinum rating as well as the official validation of its emission reduction targets by the Science Based Targets initiative (SBTi). Both achievements highlight the company’s commitment to climate protection...
Vetter reaches key launch milestones for the V-OVS® next tamper-evident syringe closure system
Ravensburg, January 15, 2026 – Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has completed several important steps in the ongoing development and upcoming launch of V-OVS® next. Developed from extensive market feedback, this new closure system will feature several important updates: intuitive handling, innovative functionality and a premium design, that fits a...
Vetter Prioritises Continuity and Action in its Sustainability Efforts
May 6, 2025, Ravensburg, Germany – Vetter, a leading global contract development and manufacturing organization (CDMO) published its fourth annual sustainability report. The report shows that the family-owned business is actively pursuing ambitious sustainability goals in climate protection, social responsibility, and business operations in a successful manner. Vetter aims to reduce its CO₂ emissions by...
Vetter boosts pharmaceutical storage capacity with major warehouse expansion
Cool storage volume to be doubled by 2028 Third expansion stage of Vetter’s Center for Visual Inspection and Logistics State-of-the art, fully automated cooled warehouse Plans for additional automated visual inspection capabilities 11 March 2025 – Ravensburg, Germany – Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), announces a significant expansion of its...
Vetter announces plans to expand its capacity in the US and Germany
Leading globally operating CDMO outlines location and design of new manufacturing sites to meet increasing customer demands Vetter Advisory Board decides on strategic path forward for further independent and sustainable growth Des Plaines, Illinois, US, and Saarlouis, Germany expansions add to an ongoing €1.5bn investment plan Vetter adds capacity within its core business of...
Vetter Becomes a Member of the German Association of Research-Based Pharmaceutical Companies (vfa)
Globally operating CDMO committed to strengthening Germany as a research and production location Association grants Vetter extraordinary membership vfa recognises the importance of pharmaceutical service providers in drug development and production Vetter serves on key vfa committees. 17 January 2024 -- Ravensburg, Germany -- Vetter, a leading globally operating contract development and manufacturing organisation (CDMO),...
- 1
- 2
